Table 2 Characteristics of different expression level of MMP1.
Characteristics | Low expression of MMP1 | High expression of MMP1 | P-value |
|---|---|---|---|
n | 543 | 544 | |
Pathologic T stage, n (%) | <0.001 | ||
T1&T2 | 433 (39.9%) | 476 (43.9%) | |
T3&T4 | 108 (10%) | 67 (6.2%) | |
Pathologic N stage, n (%) | 0.003 | ||
N0 | 267 (25%) | 249 (23.3%) | |
N1&N2 | 215 (20.1%) | 260 (24.3%) | |
N3 | 50 (4.7%) | 27 (2.5%) | |
Pathologic M stage, n (%) | 0.118 | ||
M0 | 431 (46.6%) | 474 (51.2%) | |
M1 | 6 (0.6%) | 14 (1.5%) | |
Pathologic stage, n (%) | 0.053 | ||
Stage I | 97 (9.1%) | 85 (8%) | |
Stage II | 295 (27.8%) | 324 (30.5%) | |
Stage III | 133 (12.5%) | 111 (10.4%) | |
Stage IV | 5 (0.5%) | 13 (1.2%) | |
Histological type, n (%) | <0.001 | ||
Infiltrating Lobular Carcinoma | 157 (16%) | 48 (4.9%) | |
Infiltrating Ductal Carcinoma | 322 (32.8%) | 454 (46.3%) | |
PAM50, n (%) | <0.001 | ||
LumA | 370 (35.3%) | 194 (18.5%) | |
LumB | 82 (7.8%) | 124 (11.8%) | |
Her2 | 16 (1.5%) | 66 (6.3%) | |
Basal | 54 (5.2%) | 141 (13.5%) | |
Age, n (%) | 0.036 | ||
<= 60 | 284 (26.1%) | 319 (29.3%) | |
> 60 | 259 (23.8%) | 225 (20.7%) | |
Menopause status, n (%) | 0.845 | ||
Pre | 113 (11.6%) | 117 (12%) | |
Post & Peri | 372 (38.1%) | 374 (38.3%) |
